Masaya Matsuda

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Chronic Obstructive Pulmonary Disease

Breast Cancer Cells

Allergic Rhinitis

Top Venues

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Hayato Shimora, Masaya Matsuda, Yukiko Nakayama, Hiroto Maeyama, Ryunosuke Tanioka, Yoshiyuki Tanaka, Kazuyuki Kitatani, Takeshi Nabe
Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma. Immunology 172 (4) (2024)
Hayato Shimora, Masaya Matsuda, Yukiko Nakayama, Hiroto Maeyama, Ryunosuke Tanioka, Yoshiyuki Tanaka, Kazuyuki Kitatani, Takeshi Nabe
Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma. Immunology 172 (4) (2024)
Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Hayato Shimora, Masaya Matsuda, Yukiko Nakayama, Hiroto Maeyama, Ryunosuke Tanioka, Yoshiyuki Tanaka, Kazuyuki Kitatani, Takeshi Nabe
Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma. Immunology (2024)
Yuki Ohya, Yuri Ogiso, Masaya Matsuda, Harumi Sakae, Kentaro Nishida, Yasuhiro Miki, Todd E Fox, Mark Kester, Wataru Sakamoto, Takeshi Nabe, Kazuyuki Kitatani
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells. Cells 13 (5) (2024)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Harumi Sakae, Yuri Ogiso, Masaya Matsuda, Hayato Shimora, Tye Deering, Todd E Fox, Mark Kester, Takeshi Nabe, Kazuyuki Kitatani
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma. Cells 12 (4) (2023)
Masaya Matsuda, Seito Shimizu, Kazuyuki Kitatani, Takeshi Nabe
Extracellular Vesicles Derived from Allergen Immunotherapy-Treated Mice Suppressed IL-5 Production from Group 2 Innate Lymphoid Cells. Pathogens (Basel, Switzerland) 11 (11) (2022)